Administration of diethylnitrosamine (DEN) to B6C3F1 mice at low dose (20 ppm) in drinking water for long duration resulted in formation of multifocal cystic biliary lesions in the liver. To investigate the potential of the lesions to be promoted to neoplasias by chemicals, we examined the effects of 2 different types of hepatocarcinogenesis promoters, pentachlorophenol (PCP) and phenobarbital (PB) in B6C3F1 mice. Two weeks' exposure to PCP at a concentration of 600 ppm in the diet increased 8-oxodeoxyguanosine (8-oxodG) levels in liver nuclear DNA, and cell proliferation quantified by bromodeoxyuridine (BrdU) incorporation in epithelial cells of intrahepatic bile ducts as well as hepatocytes. In mice initiated with DEN at 20 ppm in the drinking water for the first 13 weeks followed, after a 4-week recovery interval, by PCP at a concentration of 600 ppm in the diet for 25 weeks, cystic atypical hyperplasias, cholangiomas, and cholangiocarcinomas were present at statistically significant higher incidences. In contrast, neoplasia did not occur in animals treated with 500 ppm PB, and there were no elevations in 8-oxodG levels or increases in the proliferation of biliary epithelium, although proliferation was increased in hepatocytes. These findings suggest that oxidative stress due to PCP might exert a promoting action on the biliary cystic lesions produced by DEN.
INTRODUCTION
Diethylnitrosamine (DEN) has carcinogenic potential in the liver of mice, as well as other species (19) . It has been considered probable that ethylation of DNA plays a key role in DEN carcinogenesis (19) . A short-term, large-dose exposure of mice to DEN (90 mg/kg by IP injection) results in induction of hepatocellular adenomas and carcinomas, and rarely affects the intrahepatic bile ducts (1) . In contrast, DEN exposure at low dose (40 ppm in drinking water) for long-term duration causes proliferation of bile ducts (13) . We also have shown that DEN at a concentration of 20 ppm in drinking water for 14 weeks induced multiple biliary cysts in B6C3F1 mice (22) . Interestingly, at 1 month of age, transgenic mice expressing SV40 T-antigen spontaneously exhibit the same morphological lesions, multiple distended bile ducts lined by flattened epithelium. And these lesions advanced with age to multiple cystic bile ducts lined by a single layer of cuboidal to columnar epithelium, finally leading to cholangiocellular tumors (2) . Thus, if the epithelial cells composing the biliary cysts induced by DEN were already initiated, an appropriate promoting agent might cause these cells to develop into neoplasms.
Pentachlorophenol (PCP) is carcinogenic to mouse liver (6), in spite of a lack of genotoxicity (11), and exerts an enhancing effect on DEN hepatocarcinogenesis in mice (16) . We found that PCP administration to mice induced formation of 8-oxodeoxyguanosine (8-oxodG) in liver DNA and simultaneously, increase of hepatocyte cell proliferation without overt hepatotoxicity (17) . Therefore, it is likely that oxidative stress might be responsible for the observed cell proliferation and thus play a key role in its promoting action on hepatocarcinogenesis. In consideration of the fact that generation of reactive oxygen radicals occurs during redox cycling in PCP metabolism in hepatocytes (15) , oxidative stress, either reactive oxygen species or response molecules, might be able to affect intrahepatic bile duct cells adjacent to hepatocytes. In the present study, we examined whether PCP can affect the biliary cystic lesions produced by DEN. For the purpose of comparison, the effect of phenobarbital (PB), which has a promoting effect on mouse hepatocarcinogenesis (8, 14) , possibly due to inhibition of cell-cell communication (20, 21) , was also examined.
MATERIALS AND METHODS

Chemicals
PCP (purity of 98.6%), diethylnitrosamine (DEN), and phenobarbital (PB) were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Alkaline phosphatase and bromodeoxyuridine (BrdU) were obtained from Sigma Chemical Co and nuclease P1 was from Yamasa Shoyu Co Ltd (Chiba, Japan).
Animals and Exposures
The protocol for this study was approved by the Animal Care and Utilization Committee of the National Institute of Health Sciences. A total of 115 male B6C3F1 mice, 5 weeks 10 old, were purchased from Japan SLC Inc (Shizuoka, Japan). They were kept in polycarbonate cages (5 mice per cage) with hardwood chips for bedding and were housed in a conventional animal facility maintained under conditions of controlled temperature (23 ± 2 • C), humidity (60 ± 5%), air change (12 per hour), and lighting (12-hour dark/light cycle). The animals were given free access to F-2 basal diet (Funabashi Farm Co, Chiba, Japan) and tap water, and were started on the study after a 1-week acclimation period.
The mice were randomly divided into 8 groups. For the measurements of 8-oxodG levels in liver DNA and BrdU labelling index of intrahepatic biliary epithelial cells and hepatocytes, 5 animals each in groups 1-3 were given PCP at concentrations of 0 or 600 ppm in the diet, or PB at a concentration of 500 ppm in the drinking water for 2 weeks. They were given BrdU (100 mg/kg) by IP injection once a day for the final 2 days of exposure and once on the day of termination at 2 hours before being euthanatized, as previously described (18) . Animals were euthanatized under ethyl ether anesthesia, and the livers were immediately removed, and slices taken from each lobe were fixed in buffered formalin for BrdU immunostaining. The remaining pieces of the livers were frozen with a liquid nitrogen and stored at −80 • C until measurement of 8-oxodG in nuclear DNA.
Twenty animals each in groups 4 and 5 were untreated until 17 weeks after the start of the experiment and then given PCP at concentrations of 0 or 600 ppm in the diet for 25 weeks, respectively. Twenty animals each in groups 6-8 were given DEN as an initiator at 20 ppm in the drinking water for 13 weeks, and then were given either no further treatments, PCP at 600 ppm in the diet, or PB at 500 ppm in the drinking water for 25 weeks after 4 weeks recovery period to assess promoting activity. At necropsy, mice were euthanatized under the same conditions as described previously at week 42 and the livers were removed. Slices taken from each lobe were fixed in buffered-formalin and then routinely processed for embedding in paraffin and 4-µm sections were stained with hematoxylin and eosin (H&E) stain (23) . Biliary lesions were diagnosed as cystic hyperplasia, cystic atypical hyperplasia, cholangioma, and cholangiocarcinoma ( Figure 1 ).
Measurement of Nuclear 8-oxodG
The 8-oxodG levels in liver DNA were determined according to the method of Nakae et al (5) . The nuclear DNA was extracted with a DNA Extracter WB Kit (Wako Pure Chemical Industries, Ltd, Osaka, Japan). The DNA was digested to deoxynucleotides with nuclease P1 and alkaline phosphatase. 8-OxodG levels (8-oxodG/10 5 deoxyguanosine) were assessed by high-performance liquid chromatography (HPLC) equipped with an electrochemical detection system (ECD) (Coulochem II, ESA).
Immunohistochemical Procedures
For immunohistochemical staining of BrdU, after the first denaturing DNA with 4N HCl, the sections were treated sequentially with normal horse serum, monoclonal mouse anti-BrdU (Becton Dickinson) (1:100), biotin-labelled horse antimouse IgG (1:400), and avidin-biotin-peroxidase complex (ABC). The sites of peroxidase binding were demonstrated by incubation with 3,3 -diaminobenzidine tetrahydrochloride (Sigma Chemical Co). The immunostained sections were lightly counterstained with hematoxylin for microscopic examination.
Cell Proliferation Quantification
For each animal at least 1,000 bile duct epithelial cells and 3,000 hepatocytes were counted. The labeling index (LI) was calculated as the percentage of cells positive for BrdU incorporation divided by the total number of cells counted.
Statistics
The significance of differences in the results for 8-oxodG levels and LIs was evaluated with the use of ANOVA, followed by Dunnett's multiple comparison test. Regarding the initiation-promotion bioassay, the significance of differences in the results for the incidence of the intrahepatic bile duct lesions was evaluated by Fisher's exact probability test.
RESULTS
With 2 weeks' exposure of mice to PCP, 8-oxodG levels in liver nuclear DNA were increased (Table 1) , which is in accordance with our previous report (17) . In contrast, 8-oxodG levels in the livers of mice given PB in the drinking water were not changed in comparison to the control.
The LIs of intrahepatic biliary epithelial cells of mice exposed to PCP in the diet for 2 weeks were significantly increased along with elevation of the LIs of hepatocytes (Table 1) . PB also increased hepatocyte cell proliferation, but did not elicit an increase in replication in intrahepatic biliary epithelial cells.
DEN exposure for 13 weeks caused multifocal biliary cystic hyperplasia (Figure 1) , with cysts lined by flattened epithelium. The proliferating biliary lesions were classified as cystic atypical hyeperplasia, cholangioma, and cholangiocarcinoma. Cystic atypical hyperplasia has cystically dilated proliferating bile ducts lined with homogenous eosinophilic cells with elongated nuclei. The ducts in most places were not separated by a wide stroma (Figure 1 ). Cholangioma consists of proliferating cholangioles lined with more heterogenous cells showing karyomegaly, which are surrounded by dense stroma (Figure 1 ). In cholangiocarcinoma, abnormal cholangioles, in part assuming papillary forms, are lined with pleomorphic and anaplastic cells showing karyomegary and anisokaryosis and are surrounded by dense stroma (Figure 1) . The incidences and the multiplicities of bile duct lesions are given in Table 2 . Cystic hyperplasias were observed in all DEN-treated groups. Although atypical hyperplasias were observed in untreated or PB-treated groups following DEN exposure with low incidences, the incidence in mice given PCP following DEN exposure was significantly higher than that in mice given DEN alone. Furthermore, cholangiomas and cholangiocarcinomas occurred only in mice given DEN followed by PCP.
DISCUSSION
Continuous long-term administration to mice of DEN causes proliferative lesions of intrahepatic bile ducts (9, 10) . In the present study, we also showed that 13 weeks' exposure of DEN at a dose of 20 ppm in drinking water followed by 29 weeks maintenance resulted in occurrence of multiple cystic hyperplasias of intrahepatic bile ducts. It has been 12 UMEMURA ET AL TOXICOLOGIC PATHOLOGY FIGURE 1.-A) Multifocal cystic hyperplasia of intrahepatic bile ducts from a mouse given DEN at a dose of 20 ppm in drinking water for 13 weeks followed by no treatment for 29 weeks. Note multifocal cysts lined by flattened epithelium. H&E staining, ×20. B) Cystic atypical hyperplasia of intrahepatic bile ducts from a mouse given DEN at a dose of 20 ppm in drinking water for the first 13 weeks followed after a 4-week recovery interval by PB at a concentration of 500 ppm in drinking water for 25 weeks. Note multifocal cysts lined by homogenous epithelium with sideways elongated nuclei. H&E staining, ×20. C) Cholangioma from a mouse given DEN at a dose of 20 ppm in drinking water for the first 13 weeks followed after a 4-week recovery interval by PCP at a concentration of 600 ppm in diet for 25 weeks. Note proliferating cholangioles lined by heterogenous cells showing karyomegary with dense stroma. H&E staining, ×20. D) Cholangiocarcinoma from a mouse given DEN at a dose of 20 ppm in drinking water for the first 13 weeks followed after a 4-week recovery interval by PCP at a concentration of 600 ppm in diet for 25 weeks. Note proliferating cholangioles lined by pleomorphic and anaplastic cells showing karyomegary and anisokaryosis with dense stroma. H&E staining, ×20.
accepted that such lesions can result from chronic hepatic injury (3, 13) . However, the same morphological lesions spontaneously observed in SV40 T-antigen transgenic mice developed into cholangioneoplasms with age (2). In consideration of the fact that DEN exerts its carcinogenic potential as a result of formation of DNA alkylation (19) , it is possible that the observed cystic lesions already contain initiated cells.
In the present study, we demonstrated sequential progression of the lesions from cystic hyperplasias to cholangiocarcinomas under the influence of PCP. PCP produces hepatocellular neoplasms in mouse liver in spite of a lack of genotoxicity (6) . Recently, we have shown that PCP has promoting, but not initiating activity, indicating that PCP is an epigenetic carcinogen of the promoter class (16) . Also, we demonstrated that PCP caused an increase of cell proliferation in hepatocytes concomitantly with elevation of 8-oxodG in mouse liver DNA (17) . Therefore, oxidative stress might be involved in PCP promoting action. In the present study, PCP exposure for 2 weeks increased cell proliferation of bile duct epithelium, as well as hepatocytes, together with elevation of 8-oxodG formation in liver DNA. Taking into consideration possible formation of reactive oxygen radicals during redox cycling in PCP metabolism, the products of oxidative stress in hepatocytes might spread to contiguous epithelium of bile ducts. With regard to the relationship between oxidative stress and eventual promoting activity, it has been proposed that various events related to cell proliferation such as activation of early-response genes occur as a result of cellular oxidation (7) . On the other hand, PB increased cell proliferation of hepatocytes, but not bile duct epithelium, and subsequently had no effect on bile duct lesions produced by DEN. It has been proposed that functional connexin32 protein is required for hepatocellular tumor promotion by PB, indicating an effect on intercellular communications (4) . A lack of this protein in bile duct epithelium (12) might be responsible for the absence of biliary effects of PB. In conclusion, PCP was able to promote DEN-induced intrahepatic biliary cysts to cholangio neoplasms in mice possibly due to oxidative stress, which also implies the existence of the initiated cells in the flattened epithelial cells composing the biliary cysts.
